NVCR News and Press, NovoCure Limited From 04/14/21

Yesterday, Novocure's stock price made a huge jump of 50% because of an update of its LUNAR study. We look at the history of the company and the key people. Novocure already has 3 FDA approvals, 2 for glioblastoma and 1 for mesothelioma, but its total addressable market is much bi...

Yesterday, NovoCure ([[NVCR]] -5.2%) and its partner Zai Lab ([[ZLAB]] +2.7%) announced that a data monitoring committee (“DMC”) has recommended a reduced duration and sample size for its Phase 3 trial for Tumor Trial Fields (“TTF”) treatment in non-small cell...

Ongoing profitability a question mark at OrganigramCIBC analyst John Zamparo doesn't see Organigram Holdings (OGI) returning to positive EBIDTA soon, leading him to cut shares to underperformer and reducing his price target to C$3.25 from C$5.He says the COVID-19 pandemic will continue to imp...

Shares of Novocure (NASDAQ: NVCR) soared nearly 50% on Tuesday after the oncology company provided an update on a phase 3 trial of its experimental lung cancer treatment. An independent data monitoring committee (DMC) informed Novocure that an interim analysis for the study ...

Shares of NovoCure Limited (NASDAQ:NVCR) traded today at $218.12, eclipsing its 52-week high. Approximately 1.1 million shares have changed hands today, as compared to an average 30-day volume of 753,000 shares. NovoCure Ltd serves in the healthcare sector of the United States. Its busin...

Gainers: Mackinac Financial (MFNC) +56%.NovoCure (NVCR) +42%.vTv Therapeutics (VTVT) +42%.Digimarc (DMRC) +20%.PLBY Group (PLBY) +20%.Ballantyne Strong (BTN) +20%.Birks Group (BGI) +18%.Zai Lab (ZLAB) +16%.B. Riley Financial (RILY) +15%.Nam Tai Property (NTP) +14%.Losers: Brook...

After reviewing interim results from 210 patients participating in a phase 3 study, an independent monitoring committee is recommending changes to Novocure 's (NASDAQ: NVCR) non-small cell lung cancer (NSCLC) trial. Specifically, the committee is suggesting that the number of patien...

Gainers: NovoCure (NVCR) +45%, vTv Therapeutics (VTVT) +28%, Rigel Pharmaceuticals (RIGL) +15%, Zai Lab (ZLAB) +14%, Vallon Pharmaceuticals (VLON) +10%.Losers: Avenue Therapeutics (ATXI) -17%, AdaptHealth (AHCO) -17%, Brook...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of oncology firm Novocure (NASDAQ: NVCR ) stock are soaring to start the day on Tuesday following a promising update from its phase 3 tumor-treating trial . Source: CI Photos / Shutterstock.com An inde...

NovoCure Limited (NVCR) +62% after DMC recommends shorter phase 3 NSCLC trial.Mackinac Financial Corporation (MFNC) +31% on merger agreement with Nicolet Bankshares.Dragon Victory International Limited (LYL) +44%.Optibase (OBAS) +20%.Tian Ruixiang Holdings Ltd (TIRX) +26%.vTv Therap...